InSightec is conducting several clinical trials around the world to evaluate the safety and efficacy of the ExAblate MRgFUS system in relieving pain due to bone metastases, bone cancer and multiple myeloma. This non-invasive outpatient procedure, which does not involve any ionizing radiation, destroys the pain-causing nerves in the bone surface surrounding the tumor in order to relieve pain.
In most cases the treatment involves one session.
Clinical Studies and Participating Sites:
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Metastatic Bone Tumors for the Palliation of Pain
Randomized Trial comparing ExAblate MRgFUS (Magnetic Resonance-guided Focused Ultrasound Surgery) treatment of Metastatic and Multiple Myeloma Bone Tumors for the palliation of pain in patients and a Sham (no) treatment for patients who are not candidates for Radiation Therapy.
Click here to view participating sites.
Learn more about this trial at Clinical Trials.gov
____________________________________________________
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma. (Outside USA)
Click here to view participating sites.
____________________________________________________
Study to evaluate the effectiveness and safety of treatment by MR guided High Intensity focused ultrasound using conformal system in patients with pain from metastatic bone disease.
Click here to view participating sites.
Learn more about MR guided Focused Ultrasound Technology.
